help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meijssen, S.
Right arrow Articles by Erkelens, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meijssen, S.
Right arrow Articles by Erkelens, D. W.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 9 4193-4197
Copyright © 2001 by The Endocrine Society


Other Original Articles

Insulin Mediated Inhibition of Hormone Sensitive Lipase Activity in Vivo in Relation to Endogenous Catecholamines in Healthy Subjects

S. Meijssen, M. Castro Cabezas, C. G. M. Ballieux, R. J. Derksen, S. Bilecen and D. W. Erkelens

Department of Vascular Medicine, University Medical Center, 3508 GA Utrecht, The Netherlands

Address all correspondence and requests for reprints to: M. Castro Cabezas, M.D., Ph.D., Department of Vascular Medicine F02.126, University Medical Center Utrecht, P.O Box 85500, 3508 GA Utrecht, The Netherlands. E-mail: m.castrocabezas{at}azu.nl

Abstract

The regulation of hormone-sensitive lipase activity in vivo has not been studied in detail before. We have performed noninvasive in vivo tests to measure hormone-sensitive lipase activity under high plasma levels of endogenous insulin and catecholamines. For this purpose, two mental stress tests were carried out at random in 13 healthy volunteers. The subjects ingested 200 ml of a placebo solution or 20% glucose, followed by 1 h of rest, 20 min of mental stress, and 40 min of rest. Twenty minutes after the ingestion of glucose, insulin levels increased from 6.8 ± 1.6 to a maximum of 30.5 ± 4.8 mU/liter (P < 0.01), whereas the increase in insulin was significantly less after placebo (from 5.7 ± 0.9 to 9.5 ± 1.5 mU/liter; P < 0.01). The increase in heart rate, as an estimate of the amount of stress, was similar in both tests (12% increase). During stress, plasma norepinephrine and epinephrine concentrations increased by 24% and 44%, respectively, after glucose and by 4% and 21%, respectively, after placebo (n = 6). Fasting plasma FFA were similar in both tests (placebo, 0.35 ± 0.07 mM; glucose, 0.46 ± 0.08 mM). Forty minutes after ingestion of placebo, plasma FFA concentrations decreased to 0.27 ± 0.07 mM, compared with a stronger suppression to 0.11 ± 0.02 mM after ingestion of glucose (P < 0.01). By 10 min after mental stress, plasma FFA concentrations increased by 53% after placebo (P < 0.01), in contrast to unchanged FFA concentrations after ingestion of glucose. Taken together, these results suggest that the suppression of hormone-sensitive lipase by endogenous insulin in healthy, insulin-sensitive subjects is stronger than the stimulation by endogenous catecholamines.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Badeau, V. Vihma, T. S. Mikkola, A. Tiitinen, and M. J. Tikkanen
Estradiol Fatty Acid Esters in Adipose Tissue and Serum of Pregnant and Pre- and Postmenopausal Women
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4327 - 4331.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Ribalta, C. J.M. Halkes, J. Salazar, L. Masana, and M. C. Cabezas
Additive Effects of the PPAR{gamma}, APOE, and FABP-2 Genes in Increasing Daylong Triglycerides of Normolipidemic Women to Concentrations Comparable to Those in Men
Clin. Chem., May 1, 2005; 51(5): 864 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas
Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. C. Cabezas
In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1576 - 1580.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society